Amlan International to Present New Research During International Production and Processing Expo (IPPE)
13 Janeiro 2022 - 6:05PM
Amlan International, a global leader in natural, mineral-based feed
additives for poultry and livestock production, will provide
comprehensive and concise information about natural feed additives
that improve the sustainability of poultry production by leveraging
unique mineral technology to support optimal intestinal health, to
attendees of the International Production and Processing Expo
(IPPE) on Jan. 25–27, 2022, in Atlanta, GA.
"Increasing global restrictions on the use of in-feed
antibiotics has created a critical need for natural, drug-free feed
additives that can help support optimum health and productivity in
poultry," says Fred Kao, Vice President of Global Sales
with Amlan International. The global Amlan team invites IPPE
attendees to learn more about the Amlan difference in bringing
innovative solutions to improve the welfare and sustainability of
food production while also ensuring optimum production
efficiency.
“Amlan’s core competency and competitive advantage will be on
display throughout IPPE this year,” says Heath Wessels, Amlan’s
Director of Sales for North America. “Attendees will be able to
hear about our technology, interact with our experts and even hold
our mineral in their hands at our booth.”
During Alman’s educational TECHTalk presentations, renowned
poultry industry experts will share new information on tackling
poultry industry challenges. “Oral abstracts and posters of our
innovative product R&D will be presented by Amlan researchers
during the International Poultry Scientific Forum (IPSF). And
during the IPPE trade show at the Amlan booth (B5255), attendees
are invited to spend time in conversation with our representatives
about key issues impacting the global poultry and livestock
industry,” says Wade Robey, PhD, Vice President of Marketing and
Product Development.
State-of-the-Art Research to be Presented at
TECHTalks
State-of-the-art research about microbial populations inhabiting
the intestinal content and the intestinal mucosa of poultry and
livestock will be presented by Gerardo M. Nava, DVM, PhD, MSc,
Professor of Microbiology at the Universidad Autónoma de Querétaro,
Mexico. Nava’s presentation, Intestinal Microbiota:
Opportunities to Improve Intestinal Health, Welfare &
Productivity, will be presented January 26, 2022, at 3:30
p.m. Eastern Time (ET), in Hall B, booth B3649.
Carlos Augusto Mallmann, PhD, with the Laboratory of
Mycotoxicological Analysis of Federal University of Santa Maria,
Rio Grande do Sul, Brazil, is one of the world’s leading experts in
mycotoxins in poultry and livestock production. Mallmann will speak
on understanding and implementing the Mycotoxin Risk algorithm,
based on variables used to develop a reliable system for diagnosing
mycotoxicosis. Mallmann’s TECHTalk, The Mycotoxin
Risk, will be January 27, 2022, at 11:00 a.m. Eastern, in
Hall B, booth B3649.
IPSF Oral and Poster Abstracts
During the IPSF, January 24–25, 2022, Amlan experts will present
two oral abstracts and two posters, selected by IPSF, detailing
research designed to support optimal poultry intestinal health and
bring the latest production technology to producers. The research
presented in the oral abstracts was conducted in collaboration with
Imunova Análises Biológicas and University of Arkansas.
- Oral Abstract: M52, a novel natural
feed additive, preserved mucosal immune and intestinal microbial
homeostasis of broilers challenged with Eimeria
spp. by Hongyu Xue1, Fernanda Rigo2, Breno Beirão2, Celso
Fávaro2 and Max Ingberman2; 1Amlan International,
Chicago, IL, USA; 2Imunova Análises Biológicas, Curitiba, Paraná,
Brazil. Presented January 25, 2022, at 10:15 a.m. ET, in B314.
- Oral Abstract: A220, an all-natural feed additive,
reduced Salmonella intestinal
colonization in broilers and tuned down SPI-1 type III secretion
system (TTSS) virulence machinery by Hongyu Xue1, Dongping
Wang1, LeAnn Johnston1, Billy Hargis2 and Guillermo Tellez2; 1Amlan
International, Chicago, IL, USA; 2Department of Poultry Science,
University of Arkansas, Fayetteville, AR, USA. Presented January
25, 2022, at 8:45 a.m. ET, in B315.
- Poster number P319: M52, a natural coccidiostat,
improved performance, fecal oocyst shedding and intestinal lesion
score of Eimeria-infected
broilers by Hongyu Xue1, San Ching1, and LeAnn Johnston1;
1Amlan International, Chicago, IL, USA.
- Poster number P320: In vitro and in vivo evaluation of
A220, as an in-feed antibiotic alternative for enteric pathogen
control in poultry and swine by Hongyu Xue1, LeAnn
Johnston1, San Ching1 and Dongping Wang1. 1Amlan International,
Chicago, IL, USA.
IPPE Booth B5255
Amlan representatives will be interacting with trade show
attendees and focusing on Amlan’s core competency of offering
consistent, high-value, mineral-based intestinal health feed
additives with both producers and the world in mind. Amlan's
products are formulated with safe, natural ingredients that reduce
the inputs needed to raise poultry and livestock, helping to
decrease the cost and environmental impact of
production. Amlan’s unique mineral originates and is processed
in the United States and shipped globally from a single source.
Amlan products are backed-by extensive research and is supported by
Amlan’s parent company, Oil-Dri’s vertical integration.
IPPE will be held in Atlanta, GA, in the Georgia World Congress
Center, January 25–27, 2022. Following IPPE, information shared
will be available at www.amlan.com.
Company InformationAmlan is the animal health
business of Oil-Dri Corporation of America, a leading global
manufacturer and marketer of sorbent minerals.
Oil-Dri leverages over 80 years of expertise in mineral
science to selectively mine and process their unique mineral
for consumer and business-to-business markets.
Oil-Dri Corporation of America doing business as “Amlan
International” is a publicly traded stock on the New York
Stock Exchange (NYSE: ODC). Amlan International sells
feed additives across the world. Product availability may vary
by country, associated claims do not constitute medical
claims and may differ based on government requirements.
Reagan CulbertsonMedia Contactpress@amlan.com
Oil Dri Corp of America (NYSE:ODC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Oil Dri Corp of America (NYSE:ODC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024